LEGN Legend Biotech Corporation-ADR
67.17 -0.14 (-0.21%)
Market ClosedDelayed Prices By NASDAQ, in USD
LEGN
Legend Biotech Corporation-ADR price
0% Past Week
Market Cap
11.09B
Day’s Range
52W Range
Volume (3M)
534.84K
Price-Earnings Ratio
-22.97
Revenue
117.89M
Legend Biotech Corporation-ADR Latest News
A year in review: Legend Biotech Corp ADR (LEGN)’s performance in the last yearUS Post Newsabout 24 hours ago
Legend Biotech Co. (NASDAQ:LEGN) Given Consensus Recommendation of “Moderate Buy” by AnalystsThe AM Reportera day ago
Macquarie Group Ltd. Increases Stake in Legend Biotech, Demonstrating Confidence in Transformative Potential of Cell TherapyBest Stocks7 days agoAbout Legend Biotech Corporation-ADR
With an international presence, Legend Biotech Corp is a biopharmaceutical company focussing on the development of novel cell therapies for the treatment of cancers. Founded in 2014, the company is headquartered in Somerset, New Jersey, with manufacturing and administrative sites in China and Ireland. Legend Biotech Corp is listed using the ticker LEGN on the NASDAQ GS. Learn more about Legend Biotech stock by adding it to your watchlist.
Show MoreYing Huang, PhD
CEO
1.3K
Employees
2014
Founded
Somerset, New Jersey, US
HQ
Consensus
Moderate Buy
Price Target
92.00
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
35
Very Low
Industry
Avg. 47
31
Environment
38
Social
31
Governance
People Also Bought
EXEL Exelixis Inc -2.41% 
HALO Halozyme Therapeutics Inc -2.43% 
RVMD REVOLUTION Medicines Inc -1.98% 
TDC Teradata Corp -1.08% 
RARE.US Ultragenyx Pharmaceutical Inc. 1.36%